Navigation Links
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
Date:4/25/2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its first quarter ended March 31, 2013 financial results on Thursday, May 2, 2013.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, May 2, 2013 at 1:30pm Pacific Time (4:30pm Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of www.cadencepharm.com, under "Events and Presentations."  Contacts:William R. LaRueSVP & Chief Financial OfficerCadence Pharmaceuticals, Inc.858-436-1400


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
2. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
3. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
6. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
7. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
8. Cadence Pharmaceuticals to Host Analyst and Investor Day
9. Cadence to Open Finished Medical Device Facility
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
11. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  MiMedx Group, Inc. (NASDAQ: ... human amniotic tissue and patent-protected processes to develop ... Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic ... corrected the multiple inaccuracies in the press release ... the recent rulings from the Patent Trial and ...
(Date:8/27/2015)... 27, 2015 According to a ... Type (Integrated, Standalone), by Deployment Mode (Web based, On-Premise, ... Healthcare Service Providers), by Component - Global Trends & ... is estimated at $501.1 Million 2014, and is projected ... of 7.6% from 2014 to 2019. ...
(Date:8/27/2015)... , Aug. 27, 2015  Mytrus, a technology and services ... platform for electronic informed consent has received approval for ... Service (NHS). It is the first time e-Consent technology ... England . Mytrus was also ... in a clinical trial by the U.S. Food and ...
Breaking Medicine Technology:MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7
... March 6, 2012 Biospace Lab S.A. ... College London will collaborate on the development of novel ... of the Biospace Lab PhotonIMAGER™ Optima pre-clinical imaging platform. ... Dr Mark Lythgoe, and molecular probes, Dr Martin Pule, ...
... GP Strategies Corporation (NYSE: GPX ), ... sales and technical training, e-Learning solutions, management consulting and ... CFO Sharon Esposito-Mayer will speak at the ROTH Capital ... 3:30 p.m. PT. The conference will be held at ...
Cached Medicine Technology:Biospace Lab and the Centre for Advanced Biomedical Imaging at University College London to Collaborate on Development of Novel Real-Time in Vivo Optical Imaging Technologies 2
(Date:8/28/2015)... ... August 28, 2015 , ... The newest therapy to receive orphan drug ... use any time soon, according to educational website Surviving Mesothelioma. Click here to ... drug designation for mesothelioma last week from the FDA, will now head into Phase ...
(Date:8/28/2015)... ... August 28, 2015 , ... United ... to welcome TJS Insurance Group as its newest Partner Firm. Founded in 1924 ... and keeps them focused on their goals. Within the past 10 years, TJS ...
(Date:8/28/2015)... ... August 28, 2015 , ... External Counterpulsation, also known as ECP ... now selling External Counterpulsation (EECP or ECP) machines with a full clinic licence to ... in business since 2007 helping people prevent and reverse heart disease through ...
(Date:8/28/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... in order to ease the stress on the atmosphere, and lessen the number and ... the real cause of global warming and urges them to look into his studies ...
(Date:8/28/2015)... ... 2015 , ... Inc. magazine today ranked PREVENT Life Safety No. ... fastest-growing private companies. The list was unveiled online at Inc.com and is the most ... three years, PREVENT ranks higher on the list than any other company in their ...
Breaking Medicine News(10 mins):Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:Wake Up and Smell the Sick Atmosphere Says Yisrayl Hawkins in New Article This Week 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2
... Surgical Company (Nasdaq: STAA ), a developer, manufacturer ... announced the completion of a registered direct offering of 4,255,319 ... per share, which was the closing market price on June ... million because the Company did not use an underwriter for ...
... & rescue manager won contest to clone beloved pet Trakr, hero ... Can you clone a hero? ... rescue dog and 9-11 hero, Trakr, will receive five answers to ... California biotech company that is offering the first commercial dog cloning ...
... ... that it is taking sign-ups for this year,s annual subtle energies and healing conference. ... is called "Sacred Synthesis: Science with Heart". , ... Denver, CO (PRWEB) June 17, 2009 -- ISSSEEM (International ...
... ... of the clinical study that was performed using the Bariatric Advantage High Protein Meal ... Obesity (ECO). , ... Amsterdam, Holland (Vocus) June 17, 2009 -- Bariatric Advantage presented the results of the ...
... ... Remote Control 4.0. It allows help desk staff to administer and remotely control ... easy to find computers With its unique search engine. It can find the ... http://www.intelliadmin.com/blog/index.php/2009/06/remote-control-40-beta-rc4-and-usb-disabler-pro/ , ...
... ... of the University of Oklahoma, OU Physicians has established a standard of efficient patient centered ... facility was designed to consolidate the private practices for physicians teaching at the University of ... ...
Cached Medicine News:Health News:STAAR Surgical Completes Common Stock Offering 2Health News:STAAR Surgical Completes Common Stock Offering 3Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 2Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 3Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 2Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 3Health News:Bariatric Advantage High Protein Meal Replacement Clinical Study Presented at European Congress on Obesity 2Health News:Windows 7 Compatible Remote Desktop Software Released (Beta 4) 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: